We brought together a peptide studied in preclinical models for its role in gut barrier comfort, clinically researched pre- and probiotics to nourish the microbiome, and targeted tributyrin to deliver butyrate where its needed most
Researchers reported that dual-loaded chitosan nanoparticles demonstrated greater anti-proliferative activity against a breast cancer cell line compared to doxorubicin-loaded chitosan alone in these laboratory models
This study is related to long-term inhalation of high D5 levels
This included reductions in: Major adverse cardiovascular events (heart attack, stroke, cardiovascular death)
(If youre not currently working with another Brand Partner.) Ready to get started right away
Safety notes: Multi-year trials cited by the Alzheimer's Drug Discovery Foundation (2015) found no severe adverse events in older adults, and a 2002 trial of 162 patients reported no serious side effects in the treatment group